• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Word version - Health Sciences Authority
Word version - Health Sciences Authority

10_Population Pharmacokinetics
10_Population Pharmacokinetics

... Population Pharmacokinetics • It seeks to obtain relevant pharmacokinetic information in patients who are representative of the target population to be treated with the drug • It recognizes sources of variability, such as inter-subject, intra-subject, and inter-occasion, as important features that ...
Developing Risk Management Systems that meet FDA rules
Developing Risk Management Systems that meet FDA rules

... be very effective causes severe tachycardia (rapid heart rate) with excess caffeine in a genetically sensitive group. • This group can be identified by a genetic test which is costly (~$3000/person) • The drug’s profile is otherwise benign ...
SAMi_IS_2013 - updated
SAMi_IS_2013 - updated

... The AsthmaCo. June 2013 ...
T&
T&

... determine whether the polymorphic form of azithromycin was correctly stated, and whether appropriate testing was conducted to assess product performance characteristics, including stability, dissolution, and bioavailability. Pfizer also urges FDA to scrutinize pending ANDAs for generic azithromycin ...
A First-in-Man Phase 1 Clinical Trial
A First-in-Man Phase 1 Clinical Trial

The Music Never Stops
The Music Never Stops

... ■ 1x new NME to take the T-cell breaks off ■ OX40 + 2xNMEs to put T-cell gas on ■ 1x NME in Tumor microenvironment ■ 4+x NMEs in Antigen presentation Combination of tremelimumab (CTLA4) + PDL1 – The first dose ranging data was presented at AZN’s analyst meeting (this was too early to be shown in the ...
Dr. Gelzleichter: Evaluation of Carcinogenic Risk for Biotechnology
Dr. Gelzleichter: Evaluation of Carcinogenic Risk for Biotechnology

... described in ICH S6 (R1) – Requests that it is submitted early in development program (e.g., EOP2) – Includes formal evaluation of immunosuppressive potential (recommends 12 week study in cynos in combo w/ statin) – Specific interest in NK cell activity, CD8+ T cell cytolytic activity – Includes eva ...
The 4 Phases of Pharmacokinetics Pharmacokinetics Absorption
The 4 Phases of Pharmacokinetics Pharmacokinetics Absorption

... • Duringtheprocessofdrugabsorptionfromthe gastrointestinal(GI)tract,therearetwopotential sitesformetabolismofthedrugtooccur:1)gut wall,and2)liver.Ifthedrugismetabolized (chemicallyaltered)asitpassesthrougheitherof thesesites,itissaidtoundergofirstͲpas ...
December
December

... www.ismp.org/sc?id=337. The white paper supports mL as the standard unit of liquid measure used on prescription container labels for oral liquid medications. It also calls for dosing devices with numeric graduations, and for units that correspond to the container labeling to be easily and universall ...
WORKSHEET - Human Research Determination Algorithm
WORKSHEET - Human Research Determination Algorithm

... The following activities conducted or supported by the Department of Defense (DOD) are NOT research involving human subjects: Activities carried out solely for purposes of diagnosis, treatment, or prevention of injury and disease in Service members and other mission essential personnel under force h ...
Safety, Efficacy, and Pharmacokinetic Bioequivalence of Biosimilar
Safety, Efficacy, and Pharmacokinetic Bioequivalence of Biosimilar

... randomised controlled trials of licensed biologics in adults with active PsA who had failed conventional DMARD therapy. Twelve trials were identified for the PsARC network. An NMA was developed in accordance with health technology assessment guidance using a Bayesian random effects model. Because of ...
save - Tufts Center for the Study of Drug Development
save - Tufts Center for the Study of Drug Development

... human genes, with the humanized products containing more human protein sequence than the chimeric versions. Orphan drug — Drugs developed for rare diseases and conditions, which, in the United States, affect fewer than 200,000 people, or, in the European Union, affect 5 per 10,000 people or fewer. B ...
Chapter 8 GI Drugs Quiz Yourself 1. H2 receptors are special
Chapter 8 GI Drugs Quiz Yourself 1. H2 receptors are special

... acid. H2 blocker drugs block H2 receptors and prevent the release of gastric acid. 2. The trade name Antivert combines the syllables anti- from antiemetic and vert from vertigo to show that the therapeutic effect of this drug is to prevent the symptoms of nausea and vomiting from vertigo. In the tra ...
the diversion of public health
the diversion of public health

... The strategic role of IPR for TNCs • With the globalization of markets, it becomes crucial for TNC to control the use of their products in emerging markets. • Such control is realised through IPR which becomes a key source of their profits. • In the absence of IPR enforcement, counterfeiting (the r ...
How do the EMA and FDA decide which anticancer drugs make it to
How do the EMA and FDA decide which anticancer drugs make it to

... Key words: regulatory, EMA, FDA, interview study, qualitative research, anticancer medicines ...
Advanced Pharmacology-I (PHR5001) Introduction to Pharmacology
Advanced Pharmacology-I (PHR5001) Introduction to Pharmacology

... – Are the most cost-effective, most important medical development of the 20th century ...
LONGRANGE® (eprinomectin) and IVOMEC® (ivermectin) Brand
LONGRANGE® (eprinomectin) and IVOMEC® (ivermectin) Brand

... User Safety Warnings Not for Use in Humans. Keep this and all drugs out of the reach of children. The material safety data sheet (MSDS) contains more detailed occupational safety information. To report adverse effects, to obtain an MSDS, or for assistance, contact Merial at 1-888-637-4251. For addit ...
Introduction To Pharmacology
Introduction To Pharmacology

... for the fit of the drug to its receptor. • Between a quarter and a half of all drugs in use exist as stereoisomers. In most cases the stereoisomers are chiral enantiomers. Enantiomers are mirrored image twin molecules that result from the presence of an asymmetric carbon, or in a few cases, other as ...
View PDF with Images
View PDF with Images

... BY MARC BLOOMENSTEIN, OD, AND DEREK N. CUNNINGHAM, OD ...
Erectile dysfunction – non traditional methods
Erectile dysfunction – non traditional methods

... Many companies advertise their products with catchy claims like the ones mentioned above. However, if only testimonials are listed, use caution as testimonials are considered the weakest source of scientific evidence. Another thing to watch out for is the use of scientific language, as it may be use ...
factors affecting therapeutic drug monitoring
factors affecting therapeutic drug monitoring

... • In HPLC liquid containing sample is injected at one end of the column. high pressure is used to overcome resistance to flow As liquid flows some molecule move faster than others due to diff in solubility. The exact time for each molecule to flow through the column is measured by detector. The rete ...
Medication Errors
Medication Errors

... drug. It is not preapproved by any organization, nor is it recognized in any standard manuals, such as USP publications. Therefore, chemical names are primarily used by researchers, but not in medical practice. The FDA requires that either the established, or official, name or in the absence of an o ...
pharmaceutical products and drug action
pharmaceutical products and drug action

... - synthesis of _______________ (i.e. many chemically related compounds) using a process called ...
FORM 8-K - corporate
FORM 8-K - corporate

... This press release may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include all statements that do not relat ...
< 1 ... 138 139 140 141 142 143 144 145 146 ... 193 >

Biosimilar

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is a copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original ""innovator"" products, and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.Unlike the more common small-molecule drugs, biologics generally exhibit high molecular complexity, and may be quite sensitive to changes in manufacturing processes. Follow-on manufacturers do not have access to the originator's molecular clone and original cell bank, nor to the exact fermentation and purification process, nor to the active drug substance. They do have access to the commercialized innovator product.Drug related authorities such as European Medicines Agency (EMA), Food and Drug Administration (FDA), and Health Canada hold their own guidance on requirements for demonstration of the similar nature of two biological products in terms of safety and efficacy. According to them, analytical studies that demonstrate that the biological product is highly similar to the reference product notwithstanding minor differences in clinically inactive components; animal studies (including the assessment of toxicity); and a clinical study or studies (including the assessment of immunogenicity and pharmacokinetics or pharmacodynamics) that are sufficient to demonstrate safety, purity, and potency in one or more appropriate conditions of use for which the reference product is licensed and intended to be used and for which licensure is sought for the biological product.In case of a monoclonal antibody-containing medicinal product, such as Remsima, extensive physicochemical and biological characterization for it and its reference product Remicade was conducted in order to demonstrate their highly similar properties. Consequently, EMA have granted a marketing authorisation for only a few numbers of biosimilars since 2006 including a monoclonal antibody which is recently approved. Meanwhile, on March 6, 2015, the FDA approved the United States's first biosimilar product, the biosimilar filgrastim Zarxio.
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report